Boards Academy

Perioperative hypothermia and coagulopathy

T1Critical care, resuscitation and trauma·895 words · ~5 min read·v0.1✓ Sourced · 5DRAFT

Why examiners ask this

Hypothermia is the quiet complication that turns a bleeding patient into an exsanguinating one. Examiners use it to see whether you prevent rather than react, whether you understand that a normal lab coagulation panel can hide a cold patient's coagulopathy, and whether you connect temperature, acidosis and dilution into one problem. It stresses application of knowledge and judgment.

The 60-second answer

Anesthesia makes almost every patient hypothermic: induction causes redistribution of core heat to the periphery and drops core temperature 1–1.5 °C in the first hour, followed by a slower linear loss from radiation and convection; unwarmed patients typically become 1–2 °C hypothermic.1 I prevent it from the start: prewarming with forced air in holding, a room at least 21 °C while the patient is exposed, forced-air warming from induction for any anesthetic over 30 minutes, and fluids and blood of 500 mL or more warmed to 37 °C.2 I do not induce below 36.0 °C, and I record core temperature at least every 30 minutes.2 If the patient is bleeding and cold, I treat both together: aggressive rewarming toward 36 °C, correcting acidosis and calcium, balanced component therapy, and viscoelastic testing run at the patient's temperature, because standard tests warmed to 37 °C will hide the defect.

Decision points and the "why"

  • Prewarming — it reduces the core-to-periphery gradient so redistribution costs less heat; it is the single most effective preventive step and it costs 30 minutes in holding.
  • Core site — esophageal, nasopharyngeal, bladder or pulmonary artery temperature;1 skin and axillary readings lag and underestimate. I use distal esophageal in a general anesthetic.
  • Why cold bleeds — clotting factor activity falls about 10% per degree, platelet function fails, and fibrinolysis increases.3 Even mild hypothermia of less than 1 °C raises blood loss by about 16% and transfusion risk by about 22%,4 and in massively transfused trauma patients a temperature below 34 °C independently predicts death.3
  • The lab lies — PT and aPTT are run at 37 °C, so a cold patient's coagulopathy looks normal on paper. I ask for TEG or ROTEM and tell the lab the patient's temperature, or I treat clinically.
  • The lethal triad — hypothermia, acidosis and coagulopathy feed each other. In trauma I aim for damage control: short surgery, rewarm in the ICU, return later. I say this to the surgeon early.
  • Calcium — citrate in transfused blood binds ionized calcium, and a cold liver clears citrate slowly. I keep ionized calcium in the normal range, 1.1–1.3 mmol/L,3 because calcium is factor IV and low calcium also depresses contractility.
  • Rewarming targets — at least 36 °C before emergence and before ward transfer,2 because postoperative hypothermia increases myocardial events, wound infection, and prolongs neuromuscular block and drug action.

The complication they will inject

During a pelvic fracture fixation after 8 units of red cells the field is oozing everywhere, the temperature is 33.8 °C, pH 7.21, ionized calcium 0.85, and the lab INR is 1.4. I tell the surgeon we are in the lethal triad and ask for packing and a damage-control plan. I give calcium chloride 1 g, continue plasma and platelets at a 1:1:1 ratio, give cryoprecipitate or fibrinogen concentrate if fibrinogen is 150 mg/dL or less,3 and check TEG. I give tranexamic acid if within 3 hours of injury and not yet given, because later doses increased bleeding deaths in CRASH-2.5 I raise the room temperature, add a second warming blanket and an underbody pad, run every fluid through a warmer, warm the irrigation, and consider a bladder or esophageal warming device. I recheck temperature, gas and coagulation every 30 minutes and plan transfer to the ICU intubated.

Pitfalls that cost points

  • Reacting to hypothermia instead of describing prevention first.
  • Trusting a normal PT in a cold, bleeding patient.
  • Forgetting calcium during massive transfusion.
  • Treating each part of the triad in isolation rather than as one problem with damage control as the strategic answer.
  • Extubating a cold patient: shivering raises oxygen consumption up to several-fold and residual block is prolonged.

Rapid-why

Q: Why is the first-hour drop larger than later losses? A: It is redistribution, not loss: vasodilation lets core heat flow to the cooler periphery.

Q: When is deliberate hypothermia acceptable? A: Targeted temperature management after cardiac arrest and some cardiac or neurosurgical cases; otherwise normothermia is the standard.

Q: Why does shivering matter after surgery? A: It increases oxygen consumption and CO2 production; in a patient with coronary disease it provokes ischemia. Meperidine 12.5–25 mg IV stops it.

Q: Which patients cool fastest? A: Neonates, the elderly, burn patients, and those with large exposed body cavities or major regional plus general anesthesia, because both central and peripheral thermoregulation are impaired.

Numbers to know

Item Value
First-hour core drop 1–1.5 °C (redistribution)
Hypothermia definition Core < 36.0 °C2
Blood loss Rises ~16% with < 1 °C of hypothermia4
Before induction and ward transfer ≥ 36.0 °C2
Ionized calcium target 1.1–1.3 mmol/L3
Intraoperative warming Forced air if > 30 min; fluids ≥ 500 mL warmed to 37 °C2

Sources

  1. 1.Perioperative thermoregulation and heat balance · The Lancet, 2016 · pubmed.ncbi.nlm.nih.gov
  2. 2.Hypothermia: prevention and management in adults having surgery (CG65), recommendations · NICE, 2016 · nice.org.uk
  3. 3.The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition · European multidisciplinary task force (Crit Care), 2023 · pmc.ncbi.nlm.nih.gov
  4. 4.The effects of mild perioperative hypothermia on blood loss and transfusion requirement · Anesthesiology, 2008 · pubmed.ncbi.nlm.nih.gov
  5. 5.The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial · The Lancet, 2011 · researchonline.lshtm.ac.uk

Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.

Found an error or a better way your examiners phrased this? Send feedback on this page.